KUKJE PHARMA
Kukje Pharma engages in the manufacture, trade and distribution of pharmaceutical, cosmetics and health care products.
KUKJE PHARMA
Industry:
Cosmetics Health Care Medical Pharmaceutical
Founded:
1958-01-01
Status:
Active
Contact:
+82 031-781-9081
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Nginx PHP GlobalSign AlphaSSL Korea Telecom
Similar Organizations
Getz Pharma
Getz Pharma specializes in the development, manufacturing and marketing of a wide range of affordable medicines and healthcare products.
Kendai Gakari
Kendai Gakari engaging in the commercialization of breast cancer using saliva development and sales of Halal certified products.
ONO Pharmaceutical
ONO Pharmaceutical is focused on the production, purchase, and sale of pharmaceuticals and diagnostic reagents.
Stock Details
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-12-10 | OncoPep | Kukje Pharma investment in Series D - OncoPep | 11 M USD |
More informations about "Kukje Pharma"
KUKJE PHARMA Co., Ltd. - Drug pipelines, Patents, Clinical trials
Explore KUKJE PHARMA Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 5 clinical trials, Disease Domain:Infectious Diseases, Technology ...See details»
Kukje Pharma Company Profile 2024: Stock …
Dec 16, 2016 Kukje Pharma Co Ltd engages in manufacturing, importing, exporting, selling, and distributing pharmaceutical products internationally. …See details»
Kukje Pharma - Craft
Oct 29, 2024 Kukje Pharma has 2 employees at their 1 location and ₩135.37 b in annual revenue in FY 2023. See insights on Kukje Pharma including office locations, competitors, …See details»
Kukje Pharma Co., Ltd. Company Profile - Dun & Bradstreet
Kukje Pharma Co., Ltd. D&B Business Directory HOME / BUSINESS DIRECTORY / MANUFACTURING / CHEMICAL MANUFACTURING / PHARMACEUTICAL AND MEDICINE …See details»
Company Kukje Pharma Co., Ltd. - MarketScreener.com
Dec 31, 2004 Kukje Pharma Co., Ltd, formerly Kukje Pharma Ind. Co., Ltd, is a Korea-based company engaged in the manufacture of pharmaceuticals. The Companyâ s products are …See details»
Kukje Pharma - Overview, News & Similar companies - ZoomInfo
Who is Kukje Pharma. We have been honestly implementing these principles ever since the establishment. We consistently focus on R&D investment to our central research l aboratory …See details»
Kukje Pharma Co., Ltd. (002720.KS) - Yahoo Finance
See the company profile for Kukje Pharma Co., Ltd. (002720.KS) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Kukje Pharma Co., Ltd. (KRX: 002720) - Stock Analysis
Sep 13, 2024 Kukje Pharma Co., Ltd. engages in manufacturing, importing, exporting, selling, and distributing pharmaceutical products. The company offers pharmaceutical products, …See details»
Kukje Pharma Co Ltd - Company Profile and News
Company profile page for Kukje Pharma Co Ltd including stock price, company news, executives, board members, and contact informationSee details»
KSR-001 - Drug Targets, Indications, Patents - Synapse - Patsnap
5 days ago KUKJE PHARMA Co., Ltd. 100 Clinical Results associated with KSR-001. Login to view more data. 100 Translational Medicine associated with KSR-001. Login to view more …See details»
002720.KS - | Stock Price & Latest News | Reuters
Nov 15, 2024 Kukje Pharma Co., Ltd, formerly Kukje Pharma Ind. Co., Ltd, is a Korea-based company engaged in the manufacture of pharmaceuticals. The Company’s products are …See details»
Kukje Pharma Co., Ltd. Stock - MarketScreener.com
Jan 4, 2015 Kukje Pharma Co., Ltd, formerly Kukje Pharma Ind. Co., Ltd, is a Korea-based company engaged in the manufacture of pharmaceuticals. The Companyâ s products are …See details»
KJ-14003 (Kukje) - Drug Targets, Indications, Patents - Synapse
KJ-14003 (Kukje), Initially developed by KUKJE PHARMA Co., Ltd., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Eye Diseases, Active Indication ...See details»
Kukje Pharma Co., Ltd. (KRX: 002720) - Stock Analysis
Kukje Pharma Co., Ltd. engages in manufacturing, importing, exporting, selling, and distributing pharmaceutical products. The company offers pharmaceutical products, including ETC and …See details»
Kukje Pharma KOSE:A002720 Stock Report - Simply Wall St
6 days ago Research Kukje Pharma's (KOSE:A002720) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. …See details»
KJ-13001 - Drug Targets, Indications, Patents - Synapse - Patsnap
KJ-13001, Initially developed by KUKJE PHARMA Co., Ltd., Now, its global highest R&D status is Approved, Therapeutic Areas: Infectious Diseases, Active Indication ...See details»
Kukje Pharma Revenue - Stock Analysis
Oct 25, 2024 Kukje Pharma had revenue of 37.64B KRW in the quarter ending June 30, 2024, with 5.90% growth. This brings the company's revenue in the last twelve months to 142.60B, …See details»
KJ-13002 - Drug Targets, Indications, Patents - Synapse
KUKJE PHARMA Co., Ltd. Drug Highest Phase Pending Discovery. First Approval Date-Regulation-Related. 100 Clinical Results associated with KJ-13002. Login to view more data. …See details»
KSR-001-04 and KSR-001-02 and KSR-001-03 in Dry Eye …
August 23, 2021 updated by: Kukje Pharma. A Multicenter, Randomized, Double-blinded, Placebo-controlled, Parallel Phase 2b/3 Study to Evaluate the Efficacy and Safety of KSR-001 …See details»
KJ-14001 - Drug Targets, Indications, Patents - Synapse - Patsnap
KJ-14001, Initially developed by KUKJE PHARMA Co., Ltd., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Digestive System Disorders, Active ...See details»